- Population
- Healthy adults aged 21–61
- Route
- Subcutaneous
- Dose as published
- Subcutaneous ascending single doses (first trial) and two or three weekly or biweekly doses (second trial); the paper reports the well-tolerated doses as 30 or 60 µg/kg
- Frequency
- Single ascending doses; weekly or biweekly in the repeat-dose trial
- Duration
- Trials lasting 28 and 49 days
- Endpoint
- Peak and AUC of GH and IGF-I
CJC-1295 · dosing reference
What dose information exists for CJC-1295?
Two distinct molecules share this name. The published human trials used the DAC (albumin-binding) form; the non-DAC fragment sold as “Mod GRF 1-29” has no comparable published human dose data in this file.
Published human study doses
Human studyIntervention parameters reported in individual published human studies. Each study stays separate; parameters are never aggregated across studies.
Community-reported ranges
CommunityWhat people report discussing or doing in forums, on Reddit and in videos. Included only to show demand and reported practice — never as clinical evidence.
Typically discussed as roughly 100–300 mcg per kg per day for the DAC form and similar ranges for the non-DAC fragment, usually co-discussed with ipamorelin
- Community posts rarely distinguish the DAC and non-DAC molecules, which have different masses and pharmacology.
Community reports describe what people say they are doing. They are not equivalent to clinical evidence, and discussion volume says nothing about whether a practice is safe, effective or even real.
Why community reports are shown at all
People search for dose information before they search for anything else in this sector. Where discussion is widespread, pretending it does not exist helps nobody. Therapept reports the discussion — its rough shape, how common it is, and where it happens — while keeping it visibly separate from every other kind of source. Community reports describe what people say they are doing. They are not equivalent to clinical evidence.
Last reviewed 17 September 2026 · Compiled by Therapept Editorial · How these records are built
